Azacitidine for relapse of acute myeloid leukemia or myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation, multicenter PALG analysis-Reference-Cited by-同舟云学术

Azacitidine for relapse of acute myeloid leukemia or myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation, multicenter PALG analysis

Published:2021-04-04 Issue:1 Volume:107 Page:129-136
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Drozd‐Sokołowska Joanna¹^ORCID,Karakulska‐Prystupiuk Ewa¹^ORCID,Biecek Przemysław²,Kobylińska Katarzyna²,Piekarska Agnieszka³^ORCID,Dutka Magdalena³,Waszczuk‐Gajda Anna¹^ORCID,Mądry Krzysztof¹^ORCID,Kopińska Anna⁴,Gołos Aleksandra⁵,Góra‐Tybor Joanna⁶,Szwedyk Paweł⁷,Bołkun Łukasz⁸,Czyż Anna⁹,Giebel Sebastian¹⁰,Basak Grzegorz Władysław¹,Dwilewicz‐Trojaczek Jadwiga¹

Affiliation:

1. Department of Hematology, Transplantation and Internal Medicine Medical University of Warsaw Warsaw Poland

2. Faculty of Mathematics and Information Science Warsaw University of Technology Warsaw Poland

3. Department of Hematology and Transplantology Medical University of Gdansk Gdansk Poland

4. Department of Hematology and Bone Marrow Transplantation Medical University of Silesia Katowice Poland

5. Department of Hematology Institute of Hematology and Transfusion Medicine Warsaw Poland

6. Department of Hematology Medical University of Lodz Lodz Poland

7. Department of Hematology Ludwik Rydygier Hospital Cracow Poland

8. Department of Hematology Medical University of Bialystok Bialystok Poland

9. Department of Hematology Wroclaw Medical University Wroclaw Poland

10. Maria Sklodowska‐Curie Institute‐Cancer Center, Gliwice Branch Gliwice Poland

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ejh.13628

Reference27 articles.

1. Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel

2. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

3. Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML)

4. Salvage therapy with azacitidine increases regulatory T cells in peripheral blood of patients with AML or MDS and early relapse after allogeneic blood stem cell transplantation

5. In vivo administration of hypomethylating agents mitigate graft-versus-host disease without sacrificing graft-versus-leukemia

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed/Refractory Acute Myeloid Leukemia: A Single-Centre Experience;Clinical Lymphoma Myeloma and Leukemia;2023-01

2. Azacitidine and donor lymphocyte infusion for patients with relapsed acute myeloid leukemia and myelodysplastic syndromes after allogeneic hematopoietic stem cell transplantation: A meta-analysis;Frontiers in Oncology;2022-08-05

3. Acute myeloid leukemia relapse after allogeneic hematopoietic stem cell transplantation: a retrospective study from a single institution;Journal of International Medical Research;2022-02

4. Azacitidine and donor lymphocytes infusions in acute myeloid leukemia and myelodysplastic syndrome relapsed after allogeneic hematopoietic stem cell transplantation from alternative donors;Therapeutic Advances in Hematology;2022-01